Mu dheidhinn aillse / làimhseachadh / drogaichean / myeloproliferative-neoplasms

Drogaichean Ceadaichte airson Neoplasms Myeloproliferative

Tha an duilleag seo a ’liostadh dhrogaichean aillse a chaidh aontachadh leis an Rianachd Bidhe is Drugaichean (FDA) airson neoplasms myeloproliferative. Tha an liosta a ’toirt a-steach ainmean gnèitheach agus branda. Tha an duilleag seo cuideachd a ’liostadh measgachadh dhrogaichean cumanta a thathas a’ cleachdadh ann an neoplasms myeloproliferative. Tha na drogaichean fa leth anns na measgachaidhean air an aontachadh le FDA. Ach, mar as trice chan eil measgachadh dhrogaichean fhèin air aontachadh, ach tha iad air an cleachdadh gu farsaing.

Tha na h-ainmean dhrogaichean a ’ceangal ri geàrr-chunntasan Fiosrachadh Drogaichean aillse NCI. Is dòcha gu bheil drogaichean air an cleachdadh ann an neoplasms myeloproliferative nach eil air an liostadh an seo.

Drogaichean Ceadaichte airson Neoplasms Myeloproliferative

Adriamycin PFS (Doxorubicin Hydrochloride)

Adriamycin RDF (Doxorubicin Hydrochloride)

Arsenic Trioxide

Azacitidine

Cerubidine (Daunorubicin Hydrochloride)

Clafen (Cyclophosphamide)

Cyclophosphamide

Cytarabine

Cytosar-U (Cytarabine)

Cytoxan (Cyclophosphamide)

Dacogen (Decitabine)

Dasatinib

Hydrochloride Daunorubicin

Decitabine

Hydrochloride Doxorubicin

Hydrochloride Fedratinib

Gleevec (Imatinib Mesylate)

Imatinib Mesylate

Inrebic (Fedratinib Hydrochloride)

Jakafi (Ruxolitinib Phosphate)

Nilotinib

Rubidomycin (Hydrochloride Daunorubicin)

Ruxolitinib Phosphate

Sprycel (Dasatinib)

Tarabine PFS (Cytarabine)

Tasigna (Nilotinib)

Trisenox (Arsenic Trioxide)

Vidaza (Azacitidine)

Measgachadh dhrogaichean air a chleachdadh ann an neoplasms Myeloproliferative

ADE